Giroctocogene Fitelparvovec Uses, Dosage, Side Effects and more

Giroctocogene Fitelparvovec is under investigation in clinical trial NCT04370054 (Study to Evaluate the Efficacy and Safety of PF-07055480 in Moderately Severe to Severe Hemophilia a Adults).

Attribute	Details
Trade Name	Giroctocogene Fitelparvovec
Generic	Giroctocogene fitelparvovec
Giroctocogene fitelparvovec Other Names	Aav2/6-b-domain-deleted blood coagulation factor viii, Dna (recombinant adeno-associated virus 6 vector pf-07055480 human b-domain-deleted blood-coagulation factor viii-specifying), Giroctocogene fitelparvovec
Type
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	January 7, 2025 at 1:49 am

Innovators Monograph